Scholar Rock Holding Corporation (SRRK)
NASDAQ: SRRK · IEX Real-Time Price · USD
5.82
+0.03 (0.52%)
At close:
May 31, 2023, 4:00 PM
6.00
+0.18 (3.09%)
After-hours:
May 31, 2023, 6:01 PM EDT
Scholar Rock Holding Market Cap
Scholar Rock Holding has a market cap or net worth of $315.98 million as of June 1, 2023. Its market cap has increased by 72.76% in one year.
Market Cap
315.98M
Enterprise Value
105.69M
1-Year Change
72.76%
Ranking
Category
Stock Price
$5.82
Market Cap Chart
Since May 24, 2018, Scholar Rock Holding's market cap has decreased from $378.80M to $315.98M, a decrease of -16.59%. That is a compound annual growth rate of -3.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 31, 2023 | 316.00M | 0.54% |
| May 30, 2023 | 314.30M | -8.82% |
| May 26, 2023 | 344.70M | 0.47% |
| May 25, 2023 | 343.10M | -8.56% |
| May 24, 2023 | 375.20M | -8.82% |
| May 23, 2023 | 411.50M | 1.21% |
| May 22, 2023 | 406.60M | -8.44% |
| May 19, 2023 | 444.10M | 3.93% |
| May 18, 2023 | 427.30M | -3.78% |
| May 17, 2023 | 444.10M | -1.33% |
| May 16, 2023 | 450.10M | -0.46% |
| May 15, 2023 | 452.20M | 3.86% |
| May 12, 2023 | 435.40M | -0.25% |
| May 11, 2023 | 436.50M | -4.07% |
| May 10, 2023 | 455.00M | -1.52% |
| May 9, 2023 | 462.00M | 10.69% |
| May 8, 2023 | 417.40M | 2.40% |
| May 5, 2023 | 407.60M | 6.40% |
| May 4, 2023 | 383.10M | 1.08% |
| May 3, 2023 | 379.00M | 8.50% |
| May 2, 2023 | 349.30M | 0.90% |
| May 1, 2023 | 346.20M | 4.06% |
| Apr 28, 2023 | 332.70M | 0.64% |
| Apr 27, 2023 | 330.60M | -11.44% |
| Apr 26, 2023 | 373.30M | -3.09% |
View and export this data all the way back to 2018.
Start Free Trial.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cerevel Therapeutics Holdings, Inc. | 5.24B |
| Revolution Medicines, Inc. | 2.72B |
| Keros Therapeutics, Inc. | 1.45B |
| Relay Therapeutics, Inc. | 1.34B |
| IDEAYA Biosciences, Inc. | 1.27B |
| Pliant Therapeutics, Inc. | 1.27B |
| Arvinas, Inc. | 1.22B |
| Avidity Biosciences, Inc. | 771.93M |
| AnaptysBio, Inc. | 493.99M |
| IGM Biosciences, Inc. | 491.14M |
| Stoke Therapeutics, Inc. | 482.54M |
| Cullinan Oncology, Inc. | 395.58M |
| MeiraGTx Holdings plc | 391.21M |
| Mineralys Therapeutics, Inc. | 348.68M |
| Design Therapeutics, Inc. | 342.95M |
| Monte Rosa Therapeutics, Inc. | 306.18M |
| Ikena Oncology, Inc. | 216.53M |
| Werewolf Therapeutics, Inc. | 101.14M |
| Black Diamond Therapeutics, Inc. | 64.99M |
| TCR2 Therapeutics Inc. | 62.03M |
| Homology Medicines, Inc. | 58.95M |
| Passage Bio, Inc. | 55.49M |
| Atreca, Inc. | 40.14M |